$42.63 +0.03 (0.07%) Sanofi Shs Sponsored American Deposit Receipt Repr 1/2 Sh - New York Stock Exchange, Inc.

Jul. 29, 2016 | 04:00 PM

Quotes

  1. Quotes

  2. Charts

  3. Analysis

  4. Options

  5. Historical



Last Trade: 42.63
Trade Time: Jul 29 04:00 PM Eastern Daylight Time
Change: +0.03 (0.07%)
Prev Close: 42.60
Open: 41.64
Bid: 42.57
Ask: 42.70
  1. AbbVie, Merck Beat Earnings Estimates, But Sanofi Lags

    Investors Business Daily | Jul. 29, 2016 | 10:46AM EST
  2. Lilly, J&J, Novo Battle For Diabetes Market Heats Up; FDA Rulings Loom

    Investors Business Daily | Jul. 22, 2016 | 10:44AM EST
  3. Regeneron Q4 Earnings Miss Estimates Amid Slow Praluent Launch

    IBD | Feb. 9, 2016 | 11:28AM EST
  4. Walgreens Exec Buys, CVS CEO Sells Amid Market Rout

    IBD | Jan. 15, 2016 | 15:00PM EST
  5. Drug Stocks Mixed On Guidance Updates

    IBD | Jan. 12, 2016 | 18:45PM EST
  6. Sanofi, Innate Pharma Collaborate on New Bispecific NK Cell Engagers in Immuno-Oncology

    Benzinga | Jan. 11, 2016 | 05:25AM EST
  7. Sanofi, Warp Drive Bio to Collaborate on Development of Novel Oncology Therapies and Antibiotics Based on Proprietary Platforms

    Benzinga | Jan. 11, 2016 | 04:20AM EST
  8. US Stock Futures Surge After Jobs Data

    Benzinga | Jan. 8, 2016 | 08:50AM EST
  9. U.S. Stock Futures Surge After Jobs Data; El-Erian To Discuss Economic Situation

    Benzinga | Jan. 8, 2016 | 08:50AM EST
  10. Regeneron, Sanofi Announce Sarilumab Biologics License Application Accepted for Review FDA

    Benzinga | Jan. 8, 2016 | 04:01AM EST
  11. Gilead Leads 3 Drug Stocks With Top Fundamentals

    IBD | Jan. 7, 2016 | 08:02AM EST
  12. MannKind Is Plummeting

    Benzinga | Jan. 5, 2016 | 09:19AM EST
  13. Why MannKind Could Be a Value Trap

    GuruFocus | Jan. 4, 2016 | 14:15PM EST
  14. The 5 Top-Performing Big-Cap Drug Stocks Of 2015

    IBD | Dec. 30, 2015 | 14:16PM EST
  15. Sanofi Announces Dengvaxia Dengue Vaccine Approved in Brazil

    Benzinga | Dec. 28, 2015 | 05:33AM EST
Trading Center